Pfizer must correct "clarification" prospectus

Following its defeat in the Federal Supreme Court, the pharmaceutical company Pfizer must send 930,000 Swiss women a correction of previously provided information on the treatment of migraine.
The reason: the information about migraine was linked to promotional intentions and the recipients were misled by the incomplete information. At the end of 2004, a personally addressed guide with a self-test was sent out, which contained a reference to a migraine remedy that was superior to other remedies. The relatively significant risks of side effects were concealed.

The Federal Supreme Court rejected Pfizer's appeal to the administrative court and followed the argument that the attitudes of the patients addressed could well be influenced by this. According to a report in the SonntagsZeitung, the correction will cost Pfizer over one million francs.